Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Education • FinTech (& Financials services) • HealthTech (& Fitness) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Consumer |
Investing | United States |
Investment Range | $1,300,000 - $100,000,000 |
Oxeon Partners is a venture capital firm that specializes in the healthcare sector, with a particular focus on life science and healthcare services. Established in 2011 and headquartered in New York, New York, Oxeon invests in growth-stage companies that are poised to impact the healthcare industry. Their investment portfolio encompasses an extensive range of industries, including Software, IT & TMT, Education, FinTech & Financial Services, HealthTech & Fitness, Logistics & Distribution, Medical Devices & Hospital Services, Healthcare & Wellness, Investment Management, Life Science, and Consumer sectors. With a minimum investment of $1,300,000 and a maximum investment capacity of $100,000,000, Oxeon is committed to funding transformative companies. They operate with a unique model that combines executive search and investment services, positioning themselves as strategic healthcare investors. Their people-first approach is underscored by a dedication to integrity and collaboration, helping to unite visionary leaders with innovative ideas to catalyze the future of healthcare. Oxeon boasts a robust network of experienced healthcare leaders and a track record of placing over 750 executives in the last five years, with a retention rate of 91% after one year. They engage approximately 800 new leaders monthly, harnessing pattern recognition and data-driven insights to connect talent with companies revolutionizing healthcare. Oxeon's influence extends to a national reach, attracting clients that range from large established companies to VC-backed entrepreneurs across the healthcare spectrum. Their strategic investments aim to infuse category-defining companies with critical resources, often resulting in significant valuation successes.